Clinical Trials Directory

Trials / Unknown

UnknownNCT04523740

Paracetamol Discontinuation in the Elderly After Long-term Consumption

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
98 (estimated)
Sponsor
University Hospital Bispebjerg and Frederiksberg · Academic / Other
Sex
All
Age
65 Years
Healthy volunteers
Not accepted

Summary

To investigate if long-term treatment of paracetamol can be discontinued without no worsening on pain, health-related quality-of-life and level of function compared to continuing paracetamol treatment in patients aged 65 years or more.

Detailed description

Aim: To investigate if long-term treatment of paracetamol can be discontinued without worsening on pain, health-related quality-of-life and level of function compared to continuing paracetamol treatment in patients aged 65 years or more. Trial design: Patients are randomized to either arm 1: standard care (paracetamol continuation) or arm 2: experimental treatment (placebo). The investigation is double-blinded. Patients are screened and recruited from Department of respiratory medicine at Copenhagen University Hospital Bispebjerg. Patients with a daily consumption of 3 grams or more of prescribed paracetamol and who comply with the other eligibility criteria will be invited to participate in the trial and asked for written, informed consent. If given we collect data regarding the patient's medications, any medication changes during the intervention and followup, frailty (FRAIL Scale), self-reported history of falls, recent admissions, self-reported health-related quality of life (EQ-5D-5L), level of function tested by hand grib strength and sitting-rising test, and death. Data is collected at baseline and after 2 weeks when ending treatment intervention, and a 26 week follow-up.

Conditions

Interventions

TypeNameDescription
DRUGPlaceboPatients who use regular paracetamol will now receive 6 to 8 tablets of placebo per day for 2 weeks
DRUGParacetamolPatients who use regular paracetamol will now receive 6 to 8 tablets of 500 mg paracetamol per day for 2 weeks

Timeline

Start date
2020-08-01
Primary completion
2021-12-01
Completion
2021-12-01
First posted
2020-08-24
Last updated
2020-08-25

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT04523740. Inclusion in this directory is not an endorsement.